Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses

D. Hughes; J. Pink; S. Lane; M. Pirmohamed; [No Value] Hughes D.A.

doi:10.1136/bmj.d6333

Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses

D. Hughes
, J. Pink
, S. Lane
, M. Pirmohamed
, [No Value] Hughes D.A.

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-14
Journal	British Medical Journal
Volume	343
DOIs	https://doi.org/10.1136/bmj.d6333
Publication status	Published - 31 Oct 2011

Access to Document

10.1136/bmj.d6333

Cite this

@article{c193bdb706c641e1bcaadbfb376a86b5,

title = "Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses",

author = "D. Hughes and J. Pink and S. Lane and M. Pirmohamed and \{Hughes D.A.\}, \{[No Value]\}",

year = "2011",

month = oct,

day = "31",

doi = "10.1136/bmj.d6333",

language = "English",

volume = "343",

pages = "1--14",

journal = "British Medical Journal",

issn = "0959-535X",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses

AU - Hughes, D.

AU - Pink, J.

AU - Lane, S.

AU - Pirmohamed, M.

AU - Hughes D.A., [No Value]

PY - 2011/10/31

Y1 - 2011/10/31

U2 - 10.1136/bmj.d6333

DO - 10.1136/bmj.d6333

M3 - Article

SN - 0959-535X

VL - 343

SP - 1

EP - 14

JO - British Medical Journal

JF - British Medical Journal

ER -